Triglimicer LS 2mg/500mg/7.5mg Tablet
Marketer
Retra Life Science Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Triglimicer LS 2mg/500mg/7.5mg Tablet
Glycemia Control 2/500/7.5mg tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Take with food to minimize digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in that case, omit the missed dose and resume the usual regimen. Never double the dose; overdose risks hypoglycemia. Concurrent use with other antidiabetic agents, alcohol, or meal skipping may precipitate hypoglycemia; regular blood glucose monitoring is essential. Common adverse events include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing therapy, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before initiating use. Kidney function testing precedes treatment. Limit alcohol consumption, as it can heighten the risk of side effects.
Uses of Triglimicer LS 2mg/500mg/7.5mg Tablet
Managing type 2 diabetes
Major Benefits of Triglimicer LS 2mg/500mg/7.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Triglimicer LS 2mg/500mg/7.5mg tablets should be administered with a meal.
Common Side effects of Triglimicer LS 2mg/500mg/7.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triglimicer LS 2mg/500mg/7.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Triglimicer LS 2mg/500mg/7.5mg tablets with food.
How Triglimicer LS 2mg/500mg/7.5mg Tablet works:
Triglimicer LS tablets (2mg/500mg/7.5mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ different actions to optimize blood sugar management when single or dual drug regimens prove insufficient. Glimepiride (a sulfonylurea) stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin (a biguanide) reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone (a thiazolidinedione) further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Triglimicer LS 2mg/500mg/7.5mg Tablets is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimicer LS 2mg/500mg/7.5mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Triglimicer LS 2mg/500mg/7.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use the 2mg/500mg/7.5mg Triglimicer LS tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Triglimicer LS 2mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. The medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Triglimicer LS 2mg/500mg/7.5mg Tablet :
Should you forget a dose of Triglimicer LS 2mg/500mg/7.5mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimicer LS 2mg/500mg/7.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently